# A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease

> **NCT02679014** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 19 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO5459072

## Key facts

- **NCT ID:** NCT02679014
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-06
- **Primary completion:** 2016-08-28
- **Final completion:** 2016-08-28
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679014, "A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02679014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*